Contact
Please use this form to send email to PR contact of this press release:
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
TO:
Please use this form to send email to PR contact of this press release:
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
TO: